Mesenchymal stem cell transplantation improves chronic colitis-associated complications through inhibiting the activity of toll-like receptor-4 in mice

[1] Bernstein CN(2001)The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study Am J Gastroenterol 96 1116-1122

[2] Blanchard JF(2004)Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study Inflamm Bowel Dis 10 207-214

[3] Rawsthorne P(2005)The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study Gastroenterology 129 827-836

[4] Ricart E(2005)Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis Med Clin (Barc) 125 297-300

[5] Panaccione R(2011)Hepatopancreatobiliary complications among patients with inflammatory bowel disease Chin Gen Pract 14 2398-2401

[6] Loftus EV(2007)Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study Hepatology 45 1267-1274

[7] Bernstein CN(2010)The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases Hepatol Int 4 659-672

[8] Wajda A(2007)Hepatobiliary manifestations of inflammatory bowel disease Rev Esp Enferm Dig 99 525-542

[9] Blanchard JF(1995)Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 218-224

[10] Mendoza JL(1998)Alcoholic liver injury involves activation of Kupffer cells by endotoxin Am J Phys 275 G605-G611

[1] Bernstein CN(2001)The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study Am J Gastroenterol 96 1116-1122

[2] Blanchard JF(2004)Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study Inflamm Bowel Dis 10 207-214

[3] Rawsthorne P(2005)The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study Gastroenterology 129 827-836

[4] Ricart E(2005)Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn’s disease and ulcerative colitis Med Clin (Barc) 125 297-300

[5] Panaccione R(2011)Hepatopancreatobiliary complications among patients with inflammatory bowel disease Chin Gen Pract 14 2398-2401

[6] Loftus EV(2007)Incidence and risk factors for gallstones in patients with inflammatory bowel disease: a large case-control study Hepatology 45 1267-1274

[7] Bernstein CN(2010)The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases Hepatol Int 4 659-672

[8] Wajda A(2007)Hepatobiliary manifestations of inflammatory bowel disease Rev Esp Enferm Dig 99 525-542

[9] Blanchard JF(1995)Antibiotics prevent liver injury in rats following long-term exposure to ethanol Gastroenterology 108 218-224

[10] Mendoza JL(1998)Alcoholic liver injury involves activation of Kupffer cells by endotoxin Am J Phys 275 G605-G611